| ID | PMID | SEQUENCE | NAME | LENGTH | ACTIVITY |
| 1108 | 18617323 | RAGLQFPVGRLLRRLLRRLLR | Buforin IIb | 21 | IC50=12.7 µg/ml |
| 3862 | 16722632 | YA* | 8 | 2 | 12.9% inhibition at 10-6 |
| 3863 | 16722632 | YA* | 8 | 2 | 16.5% inhibition at 10-5 |
| 3864 | 16722632 | YA* | 8 | 2 | 28.1% inhibition at 10-4 |
| 3865 | 16722632 | YA* | 8 | 2 | 58.2% inhibition at 10-3 |
| 3886 | 16722632 | YSA* | 9 | 3 | 10.5% inhibition at 10-6 |
| 3887 | 16722632 | YSA* | 9 | 3 | 21.9% inhibition at 10-5 |
| 3888 | 16722632 | YSA* | 9 | 3 | 11.8% inhibition at 10-4 |
| 3889 | 16722632 | YSA* | 9 | 3 | 17.9% inhibition at 10-3 |
| 3913 | 16722632 | YSA* | 10 | 3 | 10.7% inhibition at 10-6 |
| 3914 | 16722632 | YSA* | 10 | 3 | 10.0% inhibition at 10-5 |
| 3933 | 16722632 | YSA*G | 15 | 4 | 13.6% inhibition at 10-6M |
| 3934 | 16722632 | YSA*G | 15 | 4 | 20.4% inhibition at 10-5M |
| 3935 | 16722632 | YSA*G | 15 | 4 | 14.4% inhibition at 10-4M |
| 3936 | 16722632 | YSA*G | 15 | 4 | 23.4% inhibition at 10-3M |
| 3957 | 16722632 | YRA*G | 16 | 4 | 17.0% inhibition at 10-6M |
| 3958 | 16722632 | YRA*G | 16 | 4 | 13.5% inhibition at 10-5M |
| 3959 | 16722632 | YRA*G | 16 | 4 | 13.5% inhibition at 10-4M |
| 3960 | 16722632 | YRA*G | 16 | 4 | 25.3% inhibition at 10-3M |
| 3982 | 16722632 | YA*GFM | 17 | 5 | 12.2% inhibition at 10-6M |
| 3983 | 16722632 | YA*GFM | 17 | 5 | 15.5% inhibition at 10-5M |
| 3984 | 16722632 | YA*GFM | 17 | 5 | 24.7% inhibition at 10-4M |
| 3985 | 16722632 | YA*GFM | 17 | 5 | 29.0% inhibition at 10-3M |
| 4007 | 16722632 | YA*GFM | 18 | 5 | 26.4% inhibition at 10-6M |
| 4008 | 16722632 | YA*GFM | 18 | 5 | 13.1% inhibition at 10-5M |
| 4009 | 16722632 | YA*GFM | 18 | 5 | 14.6% inhibition at 10-4M |
| 4010 | 16722632 | YA*GFM | 18 | 5 | 38.4% inhibition at 10-3M |